Tetrazolylpropionamides as inhibitors of Abeta protein production
AssigneeBristol-Myers Squibb Company
InventorMichael G. Yang
Life of this patent
Estimating the term…
Loading patent…
AssigneeBristol-Myers Squibb Company
InventorMichael G. Yang
Estimating the term…
This invention relates to novel tetrazolylpropionamides in which the amide group comprises an aminoazepinone, and related structures, of Formula (I): 1 or pharmaceutically acceptable salt or prodrug forms thereof, their pharmaceutical compositions and methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of Aβ-peptide, thereby resulting in prevention and treatment of the neuropathology associated with production of Aβ-peptide. More particularly, the present invention relates to the treatment of neurological disorders related to β-amyloid production such as Alzheimer's disease.
A compound of Formula (I):
Dependencies are inferred from the claim text.